GSI 250 Pill - white capsule/oblong, 15mm
Generic Name: tenofovir disoproxil
Pill with imprint GSI 250 is White, Capsule/Oblong and has been identified as Viread 250 mg. It is supplied by Gilead Sciences, Inc.
Viread is used in the treatment of Hepatitis B; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 250
Viread
- Generic Name
- tenofovir disoproxil
- Imprint
- GSI 250
- Strength
- 250 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-0406
- Inactive Ingredients
-
corn starch,
croscarmellose sodium,
lactose monohydrate,
microcrystalline cellulose,
magnesium stearate,
titanium dioxide,
triacetin,
hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.
More about Viread (tenofovir disoproxil)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (13)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.